Literature DB >> 25099763

Forced vital capacity predicts long-term survival for curative-resected NSCLC.

Xi Guo1, Hongxin Cao, Jun Xu, Jianyu Yu, Chunlong Zheng, Long Meng, Jiajun Du.   

Abstract

We conducted a retrospective study in patients with non-small cell lung cancer (NSCLC) who underwent curative lung resection to seek for better lung function parameters associated with long-term survival after lung resection. From January 2006 to December 2008, 470 patients who underwent lung resection with a postoperative diagnosis of NSCLC were studied. Median survival time was 60 months. Patients with pulmonary function values <80 % of predicted were defined as lung function impairment. Patients with impaired vital capacity, maximal voluntary ventilation, forced vital capacity (FVC), forced expiratory volume in one second (FEV1) or diffusion capacity for carbon monoxide (DLCO) had significant shorter overall survival time (P = 0.024; P = 0.026; P < 0.001; P = 0.027; P = 0.007). In univariate analysis, VC, FVC, FEV1 and DLCO were found to have significant effect on overall survival. In multivariate analysis, FVC (HR, 2.029; 95 % CI 1.126-3.659; P = 0.019) was found to be an independent prognostic predictor of long-term overall survival. For cancer-specific survival, FVC (HR 2.404; 95 % CI 1.300-4.445; P = 0.005) was also found to be an independent prognostic predictor in multivariable analysis. Preoperative FVC, rather than FEV1 or DLCO, is an independent prognostic predictor for long-term survival. FVC is not only an indicator of lung function but also of great value for surgeons to predict survival after lung resection.

Entities:  

Mesh:

Year:  2014        PMID: 25099763     DOI: 10.1007/s12032-014-0146-x

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  26 in total

1.  Diffusion lung capacity for carbon monoxide (DLCO) is an independent prognostic factor for long-term survival after curative lung resection for cancer.

Authors:  Michael J Liptay; Sanjib Basu; Michael C Hoaglin; Neil Freedman; L Penfield Faber; William H Warren; Zane T Hammoud; Anthony W Kim
Journal:  J Surg Oncol       Date:  2009-12-15       Impact factor: 3.454

2.  Does lobectomy for lung cancer in patients with chronic obstructive pulmonary disease affect lung function? A multicenter national study.

Authors:  Sergio Baldi; Enrico Ruffini; Sergio Harari; Gian Carlo Roviaro; Mario Nosotti; Nadia Bellaviti; Federico Venuta; Daniele Diso; Federico Rea; Claudio Schiraldi; Alberto Durigato; Maurizio Pavanello; Angelo Carretta; Piero Zannini
Journal:  J Thorac Cardiovasc Surg       Date:  2005-12       Impact factor: 5.209

3.  Fetal and placental size and risk of hypertension in adult life.

Authors:  D J Barker; A R Bull; C Osmond; S J Simmonds
Journal:  BMJ       Date:  1990-08-04

4.  Forced vital capacity, airway obstruction and survival in a general population sample from the USA.

Authors:  P G J Burney; R Hooper
Journal:  Thorax       Date:  2010-10-26       Impact factor: 9.139

5.  Forced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality.

Authors:  H M Lee; H Le; B T Lee; V A Lopez; N D Wong
Journal:  Eur Respir J       Date:  2010-06-18       Impact factor: 16.671

6.  Which pulmonary function tests best differentiate between COPD phenotypes?

Authors:  Steve H Salzman
Journal:  Respir Care       Date:  2012-01       Impact factor: 2.258

7.  Impact of COPD on pulmonary complications and on long-term survival of patients undergoing surgery for NSCLC.

Authors:  Yasuo Sekine; Mehrdad Behnia; Takehiko Fujisawa
Journal:  Lung Cancer       Date:  2002-07       Impact factor: 5.705

8.  Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease.

Authors:  D J Barker; K M Godfrey; C Fall; C Osmond; P D Winter; S O Shaheen
Journal:  BMJ       Date:  1991-09-21

9.  Lobectomy improves ventilatory function in selected patients with severe COPD.

Authors:  R J Korst; R J Ginsberg; M Ailawadi; M S Bains; R J Downey; V W Rusch; D Stover
Journal:  Ann Thorac Surg       Date:  1998-09       Impact factor: 4.330

10.  What is the predictive value of established risk factors for total and cardiovascular disease mortality when measured before middle age? Pooled analyses of two prospective cohort studies from Scotland.

Authors:  Linsay Gray; Carole L Hart; George Davey Smith; G David Batty
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2010-02
View more
  5 in total

1.  A lower level of forced expiratory volume in one second predicts the poor prognosis of small cell lung cancer.

Authors:  Hye Seon Kang; Ah Young Shin; Chang Dong Yeo; Ju Sang Kim; Yong Hyun Kim; Jin Woo Kim; Sang Haak Lee
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

2.  Maximal voluntary ventilation and forced vital capacity of pulmonary function are independent prognostic factors in colorectal cancer patients: A retrospective study of 2323 cases in a single-center of China.

Authors:  Jiangpeng Wei; Ying Zhang; Pengfei Yu; Xiuqin Li; Xiangying Feng; Shisen Li; Gang Ji; Xiaohua Li
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

3.  Low forced vital capacity predicts poor prognosis in gastric cancer patients.

Authors:  Fan Feng; Yangzi Tian; Yuan Zang; Li Sun; Liu Hong; Jianjun Yang; Man Guo; Xiao Lian; Daiming Fan; Hongwei Zhang
Journal:  Oncotarget       Date:  2017-04-25

4.  Preoperative pulmonary function correlates with systemic inflammatory response and prognosis in patients with non-small cell lung cancer: results of a single-institution retrospective study.

Authors:  Yongyin Gao; Hongdian Zhang; Yue Li; Dandan Wang; Yinlu Ma; Qing Chen
Journal:  Oncotarget       Date:  2017-04-18

5.  Effects of preoperative pulmonary function on short-term outcomes and overall survival after video-assisted thoracic surgery lobectomy.

Authors:  Yihe Wu; Yuwei Zhou; Shenhu Gao; Chengli Du; Linpeng Yao; Rong Yang
Journal:  Ann Transl Med       Date:  2021-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.